Glaxo defends handling of Avandia heart risks
Wednesday, February 24, 2010 - 13:43
in Health & Medicine
WASHINGTON (AP) -- GlaxoSmithKline said Wednesday a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "mischaracterizes and distorts" the company's record....